meso-6k_20220912.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of September 2022

Commission File Number 001-37626

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English)

Australia
(
Jurisdiction of incorporation or organization)

 

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No

 


 

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On September 12, 2022, Mesoblast Limited filed with the Australian Securities Exchange a new issue announcement, change of director’s interest notice (Appendix 3Y) which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

 



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

 

 

 

 

 

 

 

 

Mesoblast Limited

 

 

 

 

 

 

/s/ Niva Sivakumar

 

 

 

 

 

 

 

 

 

Niva Sivakumar

 

 

 

 

Company Secretary

 

 

 

Dated: September 14, 2022


 

INDEX TO EXHIBITS

 

 

 

Item

 

 

 

 

 

99.1

 

Appendix 3Y of Mesoblast Ltd, dated September 12, 2022.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

meso-ex991_6.htm

Exhibit 99.1

Appendix 3Y

Change of Director’s Interest Notice

 

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director’s Interest Notice

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01  Amended 01/01/11

 

Name of entity            MESOBLAST LIMITED

ABN                                68 109 431 870

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.  

 

Name of Director

Jane C. Bell

Date of last notice

18 August 2022

 

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest

Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

Jane Catherine Bell and Geoffrey Arthur Bell as trustees for director’s family trust

Date of change

7 September 2022

No. of securities held prior to change

114,285 ordinary shares

Class

Ordinary shares

Number acquired

133,333

Number disposed

0

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

AU$109,999.73 (AU$ 0.83 per share)

No. of securities held after change

247,618 ordinary shares

 

+ See chapter 19 for defined terms.

 

01/01/2011Appendix 3Y  Page 1

 


Appendix 3Y

Change of Director’s Interest Notice

 

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

On market share purchase

 

Part 2 – Change of director’s interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract

N/A

Nature of interest

 

 

N/A

Name of registered holder

(if issued securities)

 

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

N/A

Interest after change

N/A

 

Part 3 – +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

 

 

 

 

+ See chapter 19 for defined terms.

 

Appendix 3Y Page 2

01/01/2011